In order to address the disproportionate HIV/AIDS infection rate, the AIDS Research Consortium of Atlanta is seeking gay black men for a clinical drug trial. The study is evaluating whether tenofovir, an antiretroviral AIDS drug marketed as Viread by Gilead Sciences Inc., is safe for people who are HIV-negative.

Related Summaries